PATHOLOGICAL STATE OF THE HEPATOBILIARY SYSTEM DEPENDING ON THE TYPE OF OBESITY IN CHILDREN
Abstract
The prevalence of non-alcoholic fatty liver disease is increasing as the obesity epidemic grows worldwide, and is diagnosed at an earlier age and is pathogenetically associated with lipid metabolism pathology. Material and methods: The study involved 96 children with exogenous-constitutional obesity, who were divided into 2 groups. Group 1 with a uniform type of obesity, group 2 with abdominal obesity, and 44 healthy children with normal body weight. Lipid metabolism and liver ultrasound were studied. Results: Non-alcoholic fatty liver disease was observed in 50.0% of obese children, which occurred in 65.9% of children with visceral obesity. Non-alcoholic fatty liver disease is more common in children aged 16–18 with abdominal obesity (100%). It was found that steatosis develops earlier in obese boys than in girls and occurs against the background of clearly expressed lipid metabolism disorders. In non-alcoholic fatty liver disease, structural changes in the liver parenchyma are characterized by the simultaneous development of diffuse-focal processes, such as fatty degeneration and steatohepatitis against the background of unchanged parenchyma. Conclusion. Children with various types of obesity require comprehensive diagnostic, therapeutic and preventive measures to promptly identify disorders and reduce the risk of developing metabolic and inflammatory diseases of the hepatobiliary system and hormonal and metabolic disorders.
About the Authors
List of references
Panasenko L.M., Nefedova Zh.V., Kartseva T.V., Cherepanova M.I. The role of obesity in the development of metabolic syndrome in children. Ros Vestn Perinatol i Pediatr 2020; 65:(2): 125–132. DOI: 10.21508/1027–4065–2020–65–2–125–132 DOI: https://doi.org/10.21508/1027-4065-2020-65-2-125-132
Higgins V., Adeli K.. Pediatric metabolic syndrome: pathophysiology and laboratory assessment. EJIFCC 28(1), 25–42 (2017)
Suplotova L.A., Avdeeva V.A., Rozhinskaya L.Ya. On the issue of pathogenetic mechanisms of the influence of obesity on vitamin D levels // Obesity and Metabolism. – 2021. – Vol. 18. – No. 2. – P. 169-174. doi: https://doi.org/10.14341/omet12578. DOI: https://doi.org/10.14341/omet12578
Pigarova EA, Dzeranova LK. Obesity, diabetes mellitus, and vitamin D // Obesity and metabolism. - 2024. - Vol. 21. - No. 3. - P. 316-324. doi: https://doi.org/10.14341/omet13161 DOI: https://doi.org/10.14341/omet13161
Pigarova EA, Dzeranova LК, Yatsenko DA. Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases. Obesity and metabsm. 2022;19(1):123-133. doi: https://doi.org/10.14341/omet12835 DOI: https://doi.org/10.14341/omet12835
Nimitphong H, Guo W, Holick MF, Fried .K, Lee M. Vitamin D Inhibits Adipokine Production and Inflammatory Signaling Through the Vitamin D Receptor in Human Adipocytes. Obesity. 2021;29:562–568. doi: https://doi.org/10.1002/oby.23109 DOI: https://doi.org/10.1002/oby.23109
World Health Organisation. WHO Child growth standards: Methods and development. Geneva: WHO; 2017
Peterkova AV, Bezlepkin OB, Vasyukova OV, et al. Obesity in children. Clinical guidelines. Moscow: Ministry of Health of the Russian Federation; 2021. 77 p.
Bolotova N. V. et al. Use of transcranial magnetic therapy in combination with electrical stimulation in the correction of neuroendocrine-immune disorders in obese boys.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
